State MI
Clinical Trials in Michigan
Recruiting clinical trials with at least one study location in Michigan. Data updated daily from ClinicalTrials.gov.
Top Conditions in Michigan
Advanced Solid Tumor (6)Advanced Solid Tumors (5)Glioma (4)Multiple Myeloma (4)Metastatic Breast Cancer (4)Parkinson Disease (4)Stage IVB Prostate Cancer AJCC v8 (4)Breast Cancer (4)Chronic Lymphocytic Leukemia (4)Prostate Cancer (4)Non-Small Cell Lung Cancer (3)Head and Neck Squamous Cell Carcinoma (3)
Frequently Asked Questions — Clinical Trials in Michigan
How many clinical trials are currently recruiting in Michigan?
ClinicalMetric currently tracks 345 actively recruiting clinical trials with at least one location in Michigan. The total number of registered studies—including active but not currently enrolling trials—is 345. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Michigan?
Michigan hosts clinical trials across a broad range of medical conditions, including Advanced Solid Tumor, Advanced Solid Tumors, Glioma, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Michigan serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Michigan?
To join a clinical trial in Michigan, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Michigan maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Michigan
NCT05498207 N/A
Recruiting
Identification of Biomarkers for Stress Vulnerability and Resilience
Condition
Healthy
Enrollment
500 pts
Location
United States
Sponsor
University of Michigan
NCT07218432 N/A
Recruiting
A Study of the TheraBionic P1 Device in Breast Cancer
Condition
Breast Cancer Stage I
Enrollment
24 pts
Location
United States
Sponsor
Barbara Ann Karmanos Cancer In
NCT06976606 N/A
Recruiting
A Study to Assess Real-world Patient Characteristics and Clinical Course for Sym...
Condition
Arrhythmogenic Cardiomyopathy
Enrollment
40 pts
Location
United States
Sponsor
Lexeo Therapeutics
NCT05525247 Phase 1, Phase 2
Recruiting
A Phase 1/2, Open-label, Multicenter, Dose Escalation and Expansion Study of SLC...
Condition
Advanced Solid Tumor
Enrollment
420 pts
Location
United States, Australia, South Korea
Sponsor
Selecxine
NCT06355778 N/A
Recruiting
Adversity, Brain and Opioid Use Study
Condition
Opioid Use Disorder
Enrollment
185 pts
Location
United States
Sponsor
University of Michigan
NCT04775485 Phase 2
Recruiting
A Study to Evaluate Tovorafenib in Pediatric and Young Adult Participants With R...
Condition
Low-grade Glioma
Enrollment
141 pts
Location
United States, Australia, Canada
Sponsor
Day One Biopharmaceuticals, In
NCT06581432 Phase 2
Recruiting
Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanc...
Condition
Solid Tumours
Enrollment
430 pts
Location
United States, Australia, Belgium
Sponsor
Boehringer Ingelheim
NCT06496620 Phase 2
Recruiting
A Study to Evaluate Solrikitug in Participants With COPD (ZION)
Condition
COPD
Enrollment
171 pts
Location
United States, Australia, Canada
Sponsor
Uniquity One (UNI)
NCT05327114 Phase 2, Phase 3
Recruiting
Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory De...
Condition
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
Enrollment
201 pts
Location
United States, Argentina, Australia
Sponsor
Janssen Research & Development
NCT07076121 Phase 2, Phase 3
Recruiting
A Study Comparing BMS-986504 in Combination With Nab-paclitaxel and Gemcitabine ...
Condition
Pancreatic Ductal Adenocarcinoma
Enrollment
470 pts
Location
United States, Argentina, Australia
Sponsor
Bristol-Myers Squibb
NCT06134232 Phase 2
Recruiting
Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + ...
Condition
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Enrollment
400 pts
Location
United States
Sponsor
Dendreon
NCT06544499 Phase 3
Recruiting
A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participan...
Condition
Primary Immune Thrombocytopenia (ITP)
Enrollment
69 pts
Location
United States, Austria, Bulgaria
Sponsor
argenx
NCT04228978 N/A
Recruiting
Promote Weight Loss in Obese Peripheral Artery Disease (PAD) Patients to Prevent...
Condition
Peripheral Artery Disease
Enrollment
212 pts
Location
United States
Sponsor
Northwestern University
NCT05281471 Phase 3
Recruiting
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Phy...
Condition
Platinum-resistant Ovarian Cancer
Enrollment
186 pts
Location
United States
Sponsor
Genelux Corporation
NCT07415044 Phase 2
Recruiting
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Condition
Ulcerative Colitis (UC)
Enrollment
1,431 pts
Location
United States, Argentina, Brazil
Sponsor
Eli Lilly and Company
NCT06672185 Phase 1
Recruiting
ARC101 in Advanced Solid Tumors
Condition
Advanced Solid Tumor
Enrollment
70 pts
Location
United States, Australia, Canada
Sponsor
Third Arc Bio
NCT06136221 N/A
Recruiting
Testing LiverWatch, a Home-Based Remote-Monitoring Intervention for Advanced Liv...
Condition
Cirrhosis, Liver
Enrollment
110 pts
Location
United States
Sponsor
University of Pennsylvania
NCT07024693 Phase 2
Recruiting
DT-168 in Keratoplasty Patients With Fuchs Endothelial Corneal Dystrophy
Condition
Fuchs Endothelial Corneal Dystrophy
Enrollment
28 pts
Location
United States
Sponsor
Design Therapeutics, Inc.
NCT05421858 Phase 3
Recruiting
A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult P...
Condition
Candidemia
Enrollment
450 pts
Location
United States, Argentina, Australia
Sponsor
Basilea Pharmaceutica
NCT06600126 N/A
Recruiting
Supporting Evidence-based Responses to Emotional Needs in Emphysema
Condition
COPD
Enrollment
750 pts
Location
United States
Sponsor
University of Pennsylvania
NCT04176198 Phase 1, Phase 2
Recruiting
A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
Condition
Myelofibrosis
Enrollment
240 pts
Location
United States, Australia, Belgium
Sponsor
Sumitomo Pharma America, Inc.
NCT06951516 N/A
Recruiting
How Simplified Language Affects Comprehension and Learning in Young Children Wit...
Condition
Down Syndrome
Enrollment
30 pts
Location
United States
Sponsor
Michigan State University
NCT06596252 Phase 3
Recruiting
Once Daily Versus Twice Daily Budesonide Orodispersible Tablets for Induction of...
Condition
Eosinophilic Esophagitis
Enrollment
308 pts
Location
United States, Spain
Sponsor
Dr. Falk Pharma GmbH
NCT06636383 N/A
Recruiting
Glycogen Storage Disease Type Ia (GSDIa) Disease Monitoring Program
Condition
Glycogen Storage Disease Type Ia
Enrollment
140 pts
Location
United States, Brazil, Canada
Sponsor
Ultragenyx Pharmaceutical Inc
NCT06448754 Phase 2
Recruiting
Volrustomig Priming Regimens Exploratory Phase II Platform Study
Condition
Non-small Cell Lung Cancer
Enrollment
180 pts
Location
United States, Canada, China
Sponsor
AstraZeneca
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology